CACaption Management, LLC
Institutional investor · Portfolio as of Q3 2022
Top Holdings1,459 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
PALO ALTO NETWORKS INC | 932,600 | $152.8M | 2.1% | — | — | — | Increased — |
CHEVRON CORP | 1M | $145.9M | 2.0% | — | — | — | Increased — |
MICROSOFT CORP | 550,000 | $128.1M | 1.8% | — | — | — | New — |
DEVON ENERGY CORP | 1.8M | $109.8M | 1.5% | — | — | — | Increased — |
BIOGEN IDEC INC | 404,200 | $107.9M | 1.5% | — | — | — | Increased — |
TWITTER INC | 2.4M | $104.1M | 1.4% | — | — | — | Increased — |
SPDR S&P BIOTECH ETF | 1M | $79.3M | 1.1% | — | — | — | Increased — |
SPDR S&P BIOTECH ETF | 935,000 | $74.2M | 1.0% | — | — | — | Decreased — |
PINTEREST INC- CLASS A | 2.9M | $67.3M | 0.9% | — | — | — | Increased — |
ASCENDIS PHARMA A/S | 648,000 | $66.9M | 0.9% | — | — | — | New — |
BIOGEN IDEC INC | 249,800 | $66.7M | 0.9% | — | — | — | Increased — |
EXXON MOBIL CORP | 736,000 | $64.3M | 0.9% | — | — | — | Increased — |
DEVON ENERGY CORP | 1.1M | $63.7M | 0.9% | — | — | — | Increased — |
JOHNSON & JOHNSON | 384,000 | $62.7M | 0.9% | — | — | — | New — |
EPAM SYSTEMS INC | 170,700 | $61.8M | 0.9% | — | — | — | Increased — |
TRADE DESK INC/THE -CLASS A | 1M | $60.2M | 0.8% | — | — | — | New — |
DIAMONDBACK ENERGY INC | 488,700 | $58.9M | 0.8% | — | — | — | Unchanged — |
TRADE DESK INC/THE -CLASS A | 976,500 | $58.3M | 0.8% | — | — | — | Increased — |
DIAMONDBACK ENERGY INC | 480,000 | $57.8M | 0.8% | — | — | — | New — |
TWITTER INC | 1.3M | $56.8M | 0.8% | — | — | — | Increased — |
Caption Management, LLC manages $7.2B across 1459 positions as of Q3 2022. Top holdings: PANW (2.1%), CVX (2.0%), MSFT (1.8%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Active quarter - 230 new positions, 201 exits, 81 increased. No standout high-conviction moves this quarter. Portfolio: $7.2B across 1459 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer